Stock Target Advisor’s own stock analysis of Nutex Health is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, Nutex Health Inc’s stock price was USD 0.96. Nutex Health Inc’s stock price has changed by +0.06% over the past week, -1.66% over the past month and +0.00% over the last year.
About Nutex Health Inc. (NUTX:NSD):
Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division’s cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
What we like:
Underpriced compared to earnings
NUTX stock price is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What we don’t like:
Overpriced on cashflow basis
NUTX stock price is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the stock analysis and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
NUTX stock price is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
Nutex Health stock has shown below median revenue growth in the previous 5 years compared to its sector.